{"id":"https://openalex.org/W4385661908","doi":"https://doi.org/10.1111/ajad.13455","title":"Medication treatment for alcohol use disorder in special populations","display_name":"Medication treatment for alcohol use disorder in special populations","alternate_titles":[],"publication_year":2023,"publication_date":"2023-08-08","ids":{"openalex":"https://openalex.org/W4385661908","doi":"https://doi.org/10.1111/ajad.13455","pmid":"https://pubmed.ncbi.nlm.nih.gov/37551638"},"language":"en","primary_location":{"id":"doi:10.1111/ajad.13455","doi":"https://doi.org/10.1111/ajad.13455","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ajad.13455","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4385661908"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046407826","display_name":"Aniket Malhotra","orcid":"https://orcid.org/0009-0005-9917-4637","observed_orcids":["https://orcid.org/0009-0005-9917-4637"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aniket Malhotra","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA"],"raw_orcid":"https://orcid.org/0009-0005-9917-4637","affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086386662","display_name":"Karen P. G. Drexler","orcid":"https://orcid.org/0000-0001-5576-5703","observed_orcids":["https://orcid.org/0000-0001-5576-5703"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Drexler","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101578283","display_name":"Michael Hsu","orcid":"https://orcid.org/0000-0001-8868-8273","observed_orcids":["https://orcid.org/0000-0001-8868-8273"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Hsu","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026612674","display_name":"Yi\u2010lang Tang","orcid":"https://orcid.org/0000-0003-0958-7904","observed_orcids":["https://orcid.org/0000-0003-0958-7904"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210152539","display_name":"Atlanta VA Medical Center","ror":"https://ror.org/04z89xx32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210131075","https://openalex.org/I4210149289","https://openalex.org/I4210152539"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yi\u2010lang Tang","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA","Substance Abuse Treatment Program, Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Substance Abuse Treatment Program, Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, Georgia, USA","institution_ids":["https://openalex.org/I4210152539"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026612674"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210152539"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":0.4207,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.39372105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"32","issue":"5","first_page":"433","last_page":"441"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/disulfiram","display_name":"disulfiram","score":0.8899999856948853},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9269999861717224},{"id":"https://openalex.org/keywords/acamprosate","display_name":"acamprosate","score":1.0},{"id":"https://openalex.org/keywords/adolescents-and-young-adults","display_name":"adolescents and young adults","score":0.972000002861023},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6510000228881836},{"id":"https://openalex.org/keywords/kidney-disease","display_name":"kidney disease","score":0.7480000257492065},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7429999709129333},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C2779992327","wikidata":"https://www.wikidata.org/wiki/Q337668","display_name":"Acamprosate","level":5,"score":0.9707257747650146},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9171007871627808},{"id":"https://openalex.org/C2778523461","wikidata":"https://www.wikidata.org/wiki/Q409665","display_name":"Disulfiram","level":2,"score":0.8650779128074646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7278866767883301},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.7219986319541931},{"id":"https://openalex.org/C2779442783","wikidata":"https://www.wikidata.org/wiki/Q15326","display_name":"Alcohol use disorder","level":3,"score":0.7139157056808472},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5246022939682007},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.4668121337890625},{"id":"https://openalex.org/C2779436514","wikidata":"https://www.wikidata.org/wiki/Q4713263","display_name":"Alcohol dependence","level":3,"score":0.45585334300994873},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41654467582702637},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.17586678266525269},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17443060874938965},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.12448704242706299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11859455704689026},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077443","descriptor_name":"Acamprosate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/ajad.13455","doi":"https://doi.org/10.1111/ajad.13455","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ajad.13455","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},{"id":"pmid:37551638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37551638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal on addictions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W111370587","https://openalex.org/W170677019","https://openalex.org/W1481799070","https://openalex.org/W1517467381","https://openalex.org/W1527320858","https://openalex.org/W1635084872","https://openalex.org/W1771376650","https://openalex.org/W1898674666","https://openalex.org/W1910982087","https://openalex.org/W1965171919","https://openalex.org/W1966583118","https://openalex.org/W1978119960","https://openalex.org/W1994676680","https://openalex.org/W2022649170","https://openalex.org/W2024474319","https://openalex.org/W2026474495","https://openalex.org/W2038774592","https://openalex.org/W2040118150","https://openalex.org/W2064373853","https://openalex.org/W2074009448","https://openalex.org/W2083060011","https://openalex.org/W2086175717","https://openalex.org/W2093248443","https://openalex.org/W2097228732","https://openalex.org/W2101039973","https://openalex.org/W2101372918","https://openalex.org/W2103549216","https://openalex.org/W2107329907","https://openalex.org/W2109034809","https://openalex.org/W2125405609","https://openalex.org/W2135168571","https://openalex.org/W2143015721","https://openalex.org/W2148583169","https://openalex.org/W2153653527","https://openalex.org/W2159492208","https://openalex.org/W2164000900","https://openalex.org/W2171008207","https://openalex.org/W2183520349","https://openalex.org/W2217939607","https://openalex.org/W2273108584","https://openalex.org/W2317040133","https://openalex.org/W2341569945","https://openalex.org/W2344412319","https://openalex.org/W2467284630","https://openalex.org/W2493775166","https://openalex.org/W2544885178","https://openalex.org/W2551860952","https://openalex.org/W2587944265","https://openalex.org/W2744192774","https://openalex.org/W2752393931","https://openalex.org/W2765522818","https://openalex.org/W2782206210","https://openalex.org/W2888878676","https://openalex.org/W2899112555","https://openalex.org/W2914775968","https://openalex.org/W2991209261","https://openalex.org/W2991243110","https://openalex.org/W3000475066","https://openalex.org/W3007688002","https://openalex.org/W3028134743","https://openalex.org/W3047172548","https://openalex.org/W3099018835","https://openalex.org/W3126807600","https://openalex.org/W3128705514","https://openalex.org/W3135551605","https://openalex.org/W3180920358","https://openalex.org/W4205732724","https://openalex.org/W4214644841","https://openalex.org/W4229449778","https://openalex.org/W4295221028","https://openalex.org/W4321208151"],"related_works":["https://openalex.org/W2732821476","https://openalex.org/W4280626209","https://openalex.org/W4387917608","https://openalex.org/W4377965564","https://openalex.org/W3096740488","https://openalex.org/W4410779110","https://openalex.org/W2952666020","https://openalex.org/W3118363993","https://openalex.org/W2145677331","https://openalex.org/W2289934799"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,187],"OBJECTIVES:":[2],"Alcohol":[3],"use":[4],"disorder":[5],"(AUD)":[6],"is":[7,38,118,198],"a":[8,39,175],"significant":[9],"public":[10],"health":[11,242],"concern,":[12],"with":[13,102,165,180,196],"underutilized":[14],"effective":[15],"treatments,":[16],"particularly":[17],"in":[18,32,60,100,120,158,229],"special":[19,33,51,194,203,230],"populations.":[20,34,52],"This":[21,36],"article":[22,37],"summarizes":[23],"the":[24,44,89,190,217,225],"current":[25],"evidence":[26,150],"and":[27,57,69,83,86,95,114,141,160,178,200,235,243],"guidelines":[28],"for":[29,50,73,112,193,224],"treating":[30],"AUD":[31,48,74,155,197,228],"METHODS:":[35],"literature":[40,219],"review":[41],"that":[42],"synthesizes":[43],"latest":[45],"research":[46],"on":[47,122],"treatment":[49,135,156,167,208,226],"We":[53],"screened":[54],"242":[55],"articles":[56],"included":[58],"57":[59],"our":[61],"final":[62],"review.":[63],"RESULTS:":[64],"There":[65],"are":[66],"four":[67],"food":[68],"Drug":[70],"Administration-approved":[71],"medications":[72],"(MAUD):":[75],"disulfiram,":[76],"oral":[77],"naltrexone,":[78],"extended-release":[79],"injectable":[80],"naltrexone":[81],"(XR-NTX),":[82],"acamprosate.":[84],"Naltrexone":[85,117],"disulfiram":[87],"have":[88],"potential":[90],"to":[91,146,174,216,239],"cause":[92],"liver":[93],"toxicity,":[94],"acamprosate":[96],"should":[97,108,143,183],"be":[98,109,138,144,184],"avoided":[99],"patients":[101,121,131,164],"severe":[103],"kidney":[104],"disease.":[105],"Psychosocial":[106],"treatments":[107,182],"considered":[110,145],"first-line":[111],"pregnant":[113],"nursing":[115],"patients.":[116],"contraindicated":[119],"opioids,":[123],"as":[124],"it":[125],"may":[126,137,205],"precipitate":[127],"acute":[128],"withdrawal.":[129],"For":[130,163],"experiencing":[132],"homelessness,":[133],"nonabstinent":[134],"goals":[136],"more":[139],"practical,":[140],"XR-NTX":[142],"improve":[147,154,206,240],"adherence.":[148],"Limited":[149],"suggests":[151],"medication":[152,171,177],"can":[153],"outcomes":[157],"adolescents":[159],"young":[161],"adults.":[162],"poor":[166],"response":[168],"despite":[169],"adequate":[170],"adherence,":[172],"switching":[173],"different":[176],"augmentation":[179],"psychosocial":[181],"considered.":[185],"DISCUSSION":[186],"CONCLUSIONS:":[188],"Understanding":[189],"unique":[191],"considerations":[192],"populations":[195],"crucial,":[199],"addressing":[201],"their":[202,207],"needs":[204],"outcomes.":[209],"SCIENTIFIC":[210],"SIGNIFICANCE:":[211],"Our":[212],"study":[213],"significantly":[214],"contributes":[215],"existing":[218],"by":[220],"summarizing":[221],"crucial":[222],"information":[223],"of":[227],"populations,":[231],"highlighting":[232],"distinct":[233],"challenges,":[234],"emphasizing":[236],"tailored":[237],"approaches":[238],"overall":[241],"well-being.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4385661908","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-08-09T00:00:00"}
